Literature DB >> 33810639

First case of Arcobacter cryaerophilus in paediatric age in Spain.

C Ruiz de Alegría Puig1, M Macho Díaz, J Agüero Balbín, J Calvo Montes.   

Abstract

Entities:  

Keywords:  Arcobacter cryaerophilus; Diarrhea; Tetracyclins

Mesh:

Year:  2021        PMID: 33810639      PMCID: PMC8179946          DOI: 10.37201/req/134.2020

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN: 0214-3429            Impact factor:   1.553


× No keyword cloud information.
Sir, The genus Arcobacter, a producer of gastroenteritis in humans, is one of the so-called emerging clinical pathogens [1]. It is closely related to the genus Campylobacter and, as it, has been found to be related to the consumption of vegetables, shellfish, milk, water and meat, both beef and pork as well as poultry [2,3]. Arcobacter butzleri, Arcobacter cryaerophilus and Arcobacter skirrowii are the most related species to clinical pathology, although in the bibliography the most prevalent is A. butzleri [4]. In Spain A. butzleri, A. cryaerophilus, and A. skirrowii were detected with an overall prevalence close to 40% and were isolated from (73.3%) shellfish samples, (55%) chicken samples, (42.8%) fresh cow’s milk samples, (10%) pork samples, and (5%) beef sample [5]. Molecular and proteomic methods implemented in clinical microbiology laboratories make it significantly easy to identify, which is also necessary by the greater resistance of the genus than Campylobacter to antibiotics [6]. The ignorance of the low susceptibility to ciprofloxacin, 51% of the A. cryaerophilus strains tested resistant compared with only 13% of A. butzleri [7], can make us underestimate the importance of this enteropathogen and fail in treatment in adults. Meanwhile from 25% to 50% of the strains of Arcobacter tested in different studies were resistant to macrolides [7,8], which is the usual treatment for diarrhea in Spain for children. A 12-year-old male who goes to Primary Care consultation referring for two months, coinciding with the confinement derived from the pandemic by COVID-19, liquid bowel movements, in number of 3-4 per day, yellowish, without pathological products; refers to mild intermittent pain prior to emission, without nausea, vomiting or accompanying fever. Family does not report any symptomatology in the rest of the cohabitants (parents and brother). The family coexists with a domestic cat in perfect condition; they also do not refer to suspicions of having consumed food or beverages suspected of contamination. It was decided to collect stool sample for coproculture and parasite study, and astringent diet and oral rehydration serum on demand is recommended. From the microbiology laboratory, the negative examination for parasites and positive growth in Campylobacter medium (CCDA selective medium, Thermo Fisher Diagnostics, Hemel Hempstead, United Kingdom) was reported after two days under microaerophilia conditions at 37ºC. The colonies were identified as A. cryaerophilus with a 99.9% confidence level by MALDI-TOF Vitek-MSTM (v3.2 SARAMIS MS-ID, BioMérieux, Marcy-I’toile, France) and confirmed by sequencing the 16S rRNA gene (BlastN; Accession number: NR 025905.1). Gradient strips (Etest) were used to determine susceptibility to antibiotics and resulted resistant to cefazolin, erythromycin, amoxicillin-clavulanic and ciprofloxacin. Intermediate for imipenem and sensitive to tetracycline, doxycycline and gentamicin. When reporting the results, given the persistence of the clinic, treatment with doxycycline 100 mg was indicated every 12 hours for 5 days. Four days after the start of treatment the patient clearly improves, by decreasing in the number of bowel movements and increasing in consistency, and on the 10th day of treatment they were completely normalized. Samples were collected for coproculture in the cohabitants and rectal smears in the pet, resulting in negative both coprocultures, parasite study as well as immunochromatography for enteropathogen viruses. In the pet, also, was not identify A. cryaerophilus in the rectal smears. This clinical case serves to alert pediatricians and gastroenterologists to the appearance of this genus of emerging enteropathogens, in which the usual empirical treatment, such as the prescription of quinolones or macrolides, may have no effect, proposing the use of tetracyclines for the treatment of this infection. We would also advise microbiologists not to incubate Campylobacter plates at 42ºC but at 37ºC, or better between 25 and 30ºC since this type of enteropathogens are not thermophilic adapting in this way the protocols of clinical microbiology laboratories to the identification of this type of emerging enteropathogens. And finally, in the face of a case not related to the rural environment, it would remain to be determined the effect that COVID-19 confinement has had on food in Spain, as well as urging the institutions responsible for public health to take greater control measures on the food industries.
  8 in total

1.  Occurrence of potentially pathogenic arcobacters in shellfish.

Authors:  Anna Mottola; Elisabetta Bonerba; Maria José Figueras; Alba Pérez-Cataluña; Patrizia Marchetti; Andrea Serraino; Giancarlo Bozzo; Valentina Terio; Giuseppina Tantillo; Angela Di Pinto
Journal:  Food Microbiol       Date:  2016-01-11       Impact factor: 5.516

2.  Prevalence and genetic diversity of arcobacter in food products in the north of Spain.

Authors:  Barbara Nieva-Echevarria; Irati Martinez-Malaxetxebarria; Cecilia Girbau; Rodrigo Alonso; Aurora Fernández-Astorga
Journal:  J Food Prot       Date:  2013-08       Impact factor: 2.077

3.  Antimicrobial susceptibility testing of Arcobacter butzleri and Arcobacter cryaerophilus strains isolated from Belgian patients.

Authors:  Anne-Marie Van den Abeele; Dirk Vogelaers; Elke Vanlaere; Kurt Houf
Journal:  J Antimicrob Chemother       Date:  2016-02-06       Impact factor: 5.790

Review 4.  Insights in the pathogenesis and resistance of Arcobacter: A review.

Authors:  Susana Ferreira; João A Queiroz; Mónica Oleastro; Fernanda C Domingues
Journal:  Crit Rev Microbiol       Date:  2015-03-25       Impact factor: 7.624

Review 5.  Arcobacter: an emerging food-borne zoonotic pathogen, its public health concerns and advances in diagnosis and control - a comprehensive review.

Authors:  Thadiyam Puram Ramees; Kuldeep Dhama; Kumaragurubaran Karthik; Ramswaroop Singh Rathore; Ashok Kumar; Mani Saminathan; Ruchi Tiwari; Yashpal Singh Malik; Raj Kumar Singh
Journal:  Vet Q       Date:  2017-12       Impact factor: 3.320

6.  In vitro susceptibility of Arcobacter butzleri and Arcobacter cryaerophilus to different antimicrobial agents.

Authors:  M T Fera; T L Maugeri; M Giannone; C Gugliandolo; E La Camera; G Blandino; M Carbone
Journal:  Int J Antimicrob Agents       Date:  2003-05       Impact factor: 5.283

Review 7.  Campylobacter and Arcobacter species in food-producing animals: prevalence at primary production and during slaughter.

Authors:  Nompumelelo Shange; Pieter Gouws; Louwrens C Hoffman
Journal:  World J Microbiol Biotechnol       Date:  2019-09-06       Impact factor: 3.312

8.  Arcobacter species in humans.

Authors:  Olivier Vandenberg; Anne Dediste; Kurt Houf; Sandra Ibekwem; Hichem Souayah; Sammy Cadranel; Nicole Douat; G Zissis; J-P Butzler; P Vandamme
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.